Newsroom | 23009 results

LOS ANGELES--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) today mourned the passing of Stephen Lewis, a Canadian diplomat, humanitarian, and a prominent advocate in the global fight against HIV/AIDS. Lewis, who served as the United Nations Secretary-General’s Special Envoy for HIV/AIDS in Africa from 2001 to 2006, brought urgency, moral clarity, and global attention to a crisis that was too often overlooked at a critical moment in the epidemic. Lewis helped push the world to confront the s...

SEATTLE--(BUSINESS WIRE)--Parse Biosciences, a QIAGEN company and the leading provider of scalable and accessible single-cell sequencing solutions, today announced the commercial availability of Evercode™ Whole Transcriptome FFPE kits that are now shipping to customers. This new solution is a breakthrough that enables true whole transcriptome single cell RNA sequencing from formalin-fixed, paraffin-embedded samples. Beginning today, cancer, neuroscience, and translational researchers can access...

LOS ANGELES--(BUSINESS WIRE)--L’AIDS Healthcare Foundation (AHF) exhorte les gouvernements réunis à Yaoundé, au Cameroun, à l’occasion de la 14e Conférence ministérielle de l’OMC, à garantir le maintien du moratoire de longue date sur certains litiges en matière de propriété intellectuelle, connus sous le nom de « plaintes pour non-violation », en vertu de l’Accord de l’Organisation mondiale du commerce sur les aspects des droits de propriété intellectuelle qui touchent au commerce (ADPIC). Ce...

LOS ANGELES--(BUSINESS WIRE)--Die AIDS Healthcare Foundation (AHF) fordert die Regierungen, die sich in Yaoundé, Kamerun, zur 14. Ministerkonferenz der WTO versammelt haben, nachdrücklich auf, die Fortführung des seit langem bestehenden Moratoriums für bestimmte Streitigkeiten im Bereich des geistigen Eigentums – bekannt als „Beschwerden wegen Nichtverletzung“ – im Rahmen des Übereinkommens über handelsbezogene Aspekte der Rechte des geistigen Eigentums (TRIPS) der Welthandelsorganisation siche...

WASHINGTON--(BUSINESS WIRE)--Longhorn Vaccines and Diagnostics (LHNVD), an IND enabling-stage biopharmaceutical company, today announced new preclinical data for LHNVD-501, a half-life extended humanized monoclonal antibody targeting peptidoglycan (PGN), a structural component present in virtually all bacterial pathogens. By targeting PGN, an upstream driver of sepsis, metabolic disease, autoimmune disorders, and neurodegeneration, LHNVD-501 may address the underlying inflammatory causes of the...

MENLO PARK, Calif.--(BUSINESS WIRE)--AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical-stage biopharmaceutical company developing novel small molecule therapeutics derived from its boron chemistry platform, today announced the initiation of a Phase 2 investigator-initiated clinical trial evaluating the safety, efficacy, and pharmacokinetics of epetraborole, an orally administered inhibitor of leucyl-tRNA synthetase (LeuRS), for the treatment of pulmonary disease caused by Mycobacterium abscessu...

LOS ANGELES--(BUSINESS WIRE)--The AIDS Healthcare Foundation (AHF) is urging governments meeting in Yaoundé, Cameroon, at the WTO 14th Ministerial Conference to ensure the continuation of the longstanding moratorium on certain intellectual property disputes—known as “non-violation complaints”—under the World Trade Organization’s Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). This moratorium has helped protect countries from WTO challenges for using TRIPS flexibiliti...

TOKYO--(BUSINESS WIRE)--Meiji Seika Pharma Co., Ltd. (siège social : Chuo-ku, Tokyo ; président et directeur délégué : Toshiaki Nagasato) a annoncé aujourd’hui un investissement stratégique dans Centivax, Inc. (siège social : South San Francisco, Californie, États-Unis), une société de biotechnologie qui développe des vaccins et des traitements de nouvelle génération visant à offrir une protection universelle contre des cibles extrêmement diverses. Le programme principal de Centivax porte notam...

MINNEAPOLIS--(BUSINESS WIRE)--Provation, a leading provider of clinical productivity software, announces the launch of Provation® Mira Documentation Assist, a voice-driven documentation capability within its cloud-based GI procedure platform, Provation® Apex, enabling real-time structured documentation during procedures. This hands-free technology allows clinicians to document in real-time by simply speaking, reducing the need for manual data entry and post-procedure recall. “Mira brings docume...

TOKIO--(BUSINESS WIRE)--Meiji Seika Pharma Co., Ltd. (oficina central: Chuo-ku, Tokio; presidente y director representante: Toshiaki Nagasato) anunció hoy una inversión estratégica en Centivax, Inc. (oficina central: South San Francisco, California, EE. UU.), una empresa de biotecnología que desarrolla vacunas y terapias de próxima generación para protección universal contra dianas muy diversas. El programa principal de Centivax incluye una vacuna estacional universal contra la influenza (Centi...